Literature DB >> 7009166

Evidence for prejunctional inhibition of norepinephrine release by captopril in spontaneously hypertensive rats.

M J Antonaccio, L Kerwin.   

Abstract

Pretreatment of spontaneously hypertensive rats (SHR) with the converting enzyme inhibitor captopril (10 or 100 mg/kg p.o.) had no effect on pressor responses to angiotensin II or norepinephrine whereas the response to angiotensin I was markedly inhibited. In contrast, pressor responses to sympathetic stimulation in pithed SHR were inhibited by captopril whereas the positive chronotropic responses to stimulation were unaltered. These results suggest that captopril causes a prejunctional inhibition of norepinephrine release to sympathetic nerve stimulation which is selective for the vasculature. This is probably due to inhibition of angiotensin II formation in the vasculature.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7009166     DOI: 10.1016/0014-2999(80)90325-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure.

Authors:  S Kasama; T Toyama; T Hatori; H Sumino; H Kumakura; Y Takayama; S Ichikawa; T Suzuki; M Kurabayashi
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

2.  Influence of the renin-angiotensin system on sympathetic neurotransmission in canine skeletal muscle in vivo.

Authors:  J H Schwieler; T Kahan; J Nussberger; P Hjemdahl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

Review 3.  Why are converting enzyme inhibitors vasodilators?

Authors:  P M Vanhoutte; W Auch-Schwelk; M L Biondi; R R Lorenz; V B Schini; M J Vidal
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 4.  Preclinical studies on angiotensin converting enzyme inhibitors.

Authors:  I L Natoff
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

5.  Effect of captopril on changes in plasma noradrenaline induced by sodium nitroprusside.

Authors:  R H Becker; A D Struthers; M J Brown
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

6.  Converting enzyme inhibitors in hypertension and heart failure.

Authors:  H J Dargie; S G Ball; A B Atkinson; J I Robertson
Journal:  Br Heart J       Date:  1983-04

7.  Enalapril reduces the catecholamine response to exercise in patients with heart failure.

Authors:  B P McGrath; L F Arnolda
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Induction of a reduction in haemoglobin concentration by enalapril in stable, moderate heart failure: a double blind study.

Authors:  B Herrlin; O Nyquist; C Sylvén
Journal:  Br Heart J       Date:  1991-09

9.  Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition.

Authors:  K Silberbauer; B Stanek; H Templ
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 10.  [Captopril in congestive heart failure (author's transl)].

Authors:  G Liebau
Journal:  Klin Wochenschr       Date:  1982-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.